ASCO Tumor Boards: Metastatic Colon Cancer

Product ID : ATB1802
Price: $15.00
You will receive a link to your product from customerservice@asco.org within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend

Purchase

Description

This is a case-based activity that includes discussion of a 69-year-old woman with positive fecal occult blood test (FOBT), who underwent a colonoscopy showing hepatic flexure adenocarcinoma. The patient then underwent hemicolectomy, staging pT3 N2 cM0.

At the end of this course, learners should be able to:

  • Examine the important clinical and molecular subgroups of advanced colorectal cancer
  • Explain the relevance of extended RAS mutations and BRAF beyond KRAS exon 2 in current practice
  • Determine the impact of side of primary on prognosis and treatment choice
  • Discuss the additional mutations beyond RAS and RAF, i.e. Her 2, MSI/dMMR, and impact on therapy

IMPORTANT NOTE: This course expires on March 21, 2020. Participants must complete all necessary course components by this date.

Purchase the 2018 ASCO Tumor Boards Bundle to access to all 2018 ASCO Tumor Boards for added savings. Purchased separately, these items would be $90 altogether. When bundled, you save $25.

Recommended Products